Metalloenzymes: Functions and Biomedical Applications
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Bioorganic Chemistry".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 1205
Special Issue Editors
Interests: structural biology; X-ray crystallography; proteins; protein-ligand complexes
Special Issues, Collections and Topics in MDPI journals
Interests: structural biology; X-ray crystallography
Interests: structural biology; X-ray crystallography; biochemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Metalloenzymes are a widespread class of proteins found in all kingdom of life, which utilize a metal ion to promote catalysis. Several studies have been reported on these enzymes clarifying both their structural features and their mechanism of action and highlighting their essential role in fundamental biological activities, such as nucleic acid modification, protein degradation, photosynthesis, water oxidation, and many others. The role of metalloenzymes in these processes makes them central in the outbreak or the progression of many diseases, including cancer, neurodegenerative disorders, diabetes, bacterial infections, and rheumatoid arthritis. As a consequence, these enzymes have become attractive targets for therapeutic interventions, and several high-affinity ligands, able to modulate their activity, have been successfully developed.
The present Special Issue aims to summarize the most important results recently obtained on the functions and biomedical applications of metalloenzymes.
Dr. Vincenzo Alterio
Dr. Katia D'Ambrosio
Dr. Anna Di Fiore
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug targets
- inhibitor development
- oxidoreductases
- phosphodiesterases
- peptidases
- hydrolase
- lyases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.